Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...
A comprehensive product overview including the AIRSUPRA description, mechanism of action, dosage and administration, research and development activities in Asthma. Elaborated details on AIRSUPRA ...
A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy. The phase 3b BATURA study showed Airsupra ...
5.3.2. Market Size of AIRSUPRA in Germany for Asthma 5.3.3. Market Size of AIRSUPRA in France for Asthma 5.3.4. Market Size of AIRSUPRA in Italy for Asthma 5.3.5. Market Size of AIRSUPRA in Spain ...
This report provides comprehensive insights about AIRSUPRA for Asthma in the seven major markets. A comprehensive product overview including the AIRSUPRA description, mechanism of action, dosage and ...
A comprehensive product overview including the AIRSUPRA description, mechanism of action, dosage and administration, research and development activities in Asthma. Elaborated details on AIRSUPRA ...